Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
10,163
-1,431
-12% -$177K 0.01% 226
2025
Q4
$1.46M Sell
11,594
-5,276
-31% -$688K 0.01% 219
2025
Q3
$2.47M Sell
16,870
-189,941
-92% -$28.7M 0.01% 197
2025
Q2
$32.3M Sell
206,811
-39,643
-16% -$6.29M 0.16% 108
2025
Q1
$40.6M Buy
246,454
+83,646
+51% +$13.9M 0.21% 95
2024
Q4
$26.5M Buy
162,808
+4,522
+3% +$809K 0.14% 103
2024
Q3
$30.9M Buy
158,286
+10,382
+7% +$1.91M 0.16% 98
2024
Q2
$25.6M Buy
147,904
+117,727
+390% +$19.6M 0.14% 95
2024
Q1
$5.11M Sell
30,177
-2,178
-7% -$408K 0.03% 168
2023
Q4
$6.39M Sell
32,355
-477
-1% -$84.4K 0.04% 151
2023
Q3
$5.71M Sell
32,832
-772
-2% -$140K 0.04% 150
2023
Q2
$5.79M Sell
33,604
-3,154
-9% -$545K 0.04% 151
2023
Q1
$6.12M Sell
36,758
-5,675
-13% -$930K 0.03% 146
2022
Q4
$6.22M Sell
42,433
-5,065
-11% -$750K 0.04% 141
2022
Q3
$7.04M Sell
47,498
-1,802
-4% -$301K 0.05% 136
2022
Q2
$8.47M Buy
49,300
+3,754
+8% +$649K 0.06% 129
2022
Q1
$8.59M Buy
45,546
+4,621
+11% +$913K 0.06% 118
2021
Q4
$9.99M Buy
40,925
+4,225
+12% +$925K 0.06% 124
2021
Q3
$7.13M Buy
36,700
+322
+0.9% +$65K 0.04% 135
2021
Q2
$6.78M Sell
36,378
-735
-2% -$128K 0.04% 140
2021
Q1
$5.84M Sell
37,113
-4,114
-10% -$652K 0.04% 147
2020
Q4
$6.82M Buy
41,227
+498
+1% +$81K 0.04% 129
2020
Q3
$6.74M Buy
40,729
+728
+2% +$112K 0.05% 121
2020
Q2
$5.48M Hold
40,001
0.04% 135
2020
Q1
$4.71M Hold
40,001
0.04% 134
2019
Q4
$5.29M Buy
40,001
+45
+0.1% +$5.59K 0.04% 142
2019
Q3
$4.98M Buy
39,956
+582
+1% +$70.3K 0.04% 143
2019
Q2
$4.47M Buy
39,374
+19,619
+99% +$2.05M 0.03% 152
2019
Q1
$1.99M Sell
19,755
-1,120
-5% -$102K 0.02% 212
2018
Q4
$1.79M Hold
20,875
0.02% 205
2018
Q3
$1.91M Hold
20,875
0.02% 215
2018
Q2
$1.78M Buy
20,875
+74
+0.4% +$6.25K 0.02% 225
2018
Q1
$1.74M Sell
20,801
-150
-0.7% -$11.8K 0.02% 227
2017
Q4
$1.51M Buy
20,951
+150
+0.7% +$10.3K 0.02% 241
2017
Q3
$1.33M Hold
20,801
0.01% 239
2017
Q2
$1.3M Sell
20,801
-496
-2% -$29.3K 0.01% 232
2017
Q1
$1.14M Sell
21,297
-407
-2% -$22K 0.01% 239
2016
Q4
$1.16M Buy
21,704
+527
+2% +$26.8K 0.01% 231
2016
Q3
$1.1M Sell
21,177
-282
-1% -$14.3K 0.01% 224
2016
Q2
$1.02M Sell
21,459
-896
-4% -$42.3K 0.01% 224
2016
Q1
$991K Buy
22,355
+261
+1% +$11.1K 0.01% 225
2015
Q4
$1.06M Sell
22,094
-1,125
-5% -$50.8K 0.01% 223
2015
Q3
$956K Hold
23,219
0.01% 230
2015
Q2
$1.12M Hold
23,219
0.02% 222
2015
Q1
$1.07M Sell
23,219
-179
-0.8% -$8.07K 0.01% 215
2014
Q4
$1.01M Buy
23,398
+300
+1% +$12.2K 0.01% 219
2014
Q3
$853K Hold
23,098
0.01% 226
2014
Q2
$745K Sell
23,098
-939
-4% -$28.8K 0.01% 233
2014
Q1
$695K Sell
24,037
-221
-0.9% -$6.75K 0.01% 232
2013
Q4
$793K Buy
24,258
+418
+2% +$13.3K 0.01% 216
2013
Q3
$742K Buy
23,840
+298
+1% +$9.13K 0.01% 212
2013
Q2
$727K Buy
+23,542
New +$762K 0.01% 210

Other funds holding ZTS

Bahl & Gaynor's ZTS Position: Q1 2026 in Review

Bahl & Gaynor reduced its Zoetis (ZTS) stake by 12% in Q1 2026, selling an estimated $177K and leaving 10,163 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #226.

Bahl & Gaynor first reported a position in ZTS in Q2 2013 and has held it in 52 quarters since. The position peaked at $40.6M in Q1 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Bahl & Gaynor held 10,163 shares of Zoetis worth $1.2M as of Q1 2026.
  • Bahl & Gaynor sold 1,431 Zoetis shares in Q1 2026, an estimated $177K.
  • Zoetis made up 0.01% of Bahl & Gaynor's portfolio in Q1 2026, its #226 holding.
  • Bahl & Gaynor first reported a position in Zoetis in Q2 2013 and has held it in 52 quarters since.
  • Bahl & Gaynor's Zoetis position peaked at $40.6M in Q1 2025.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.